Cargando…
Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
Dipeptidyl peptidase 4 (DPP4) is recognised as an attractive anti-diabetic drug target, and several DPP4 inhibitors are already on the market. As members of the same gene family, dipeptidyl peptidase 8 (DPP8) and dipeptidyl peptidase 9 (DPP9) share high sequence and structural homology as well as fu...
Autores principales: | Liu, Jinglong, Huan, Yi, Li, Caina, Liu, Minzhi, Shen, Zhufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590293/ https://www.ncbi.nlm.nih.gov/pubmed/26579375 http://dx.doi.org/10.1016/j.apsb.2013.12.007 |
Ejemplares similares
-
DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages
por: de Vasconcelos, Nathalia M, et al.
Publicado: (2019) -
DPP4 in Diabetes
por: Röhrborn, Diana, et al.
Publicado: (2015) -
Clinical Use of DPP-4 Inhibitors
por: Gallwitz, Baptist
Publicado: (2019) -
Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021) -
Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor
por: Wang, Aiying, et al.
Publicado: (2012)